| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 34.37× | 34.37× | 41.27× | 47.35× | 42.25× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −2.26× | −2.15× | −2.16× | 5.05× | 6.84× | ||
| 0.49× | 0.49× | 0.46× | 0.57× | 0.75× | ||
| 3.40× | 3.40× | −0.64× | 0.07× | 1.31× | ||
| 0.72× | 0.72× | 0.38× | −0.14× | 0.26× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 42.25 | 47.35 | 41.27 | 34.37 | 34.37 | |
| Working Capital Turnover | 6.84 | 5.05 | -2.16 | -2.15 | -2.26 | |
| Asset Turnover | 0.75 | 0.57 | 0.46 | 0.49 | 0.49 | |
| Cash Conversion (CFO/Net Income) | 1.31 | 0.07 | -0.64 | 3.40 | 3.40 | |
| CFO/EBITDA | 0.26 | -0.14 | 0.38 | 0.72 | 0.72 |